Details for Patent: 8,415,337
✉ Email this page to a colleague
Which drugs does patent 8,415,337 protect, and when does it expire?
Patent 8,415,337 protects NEOPROFEN and is included in one NDA.
Summary for Patent: 8,415,337
| Title: | Ibuprofen compositions and methods of making same |
| Abstract: | The present invention provides an improved ibuprofen lysine pharmaceutical composition and a process for preparing the same. |
| Inventor(s): | Aravind Krishna |
| Assignee: | Recordati Rare Diseases Inc |
| Application Number: | US13/410,989 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,415,337 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Delivery; Dosage form; |
Drugs Protected by US Patent 8,415,337
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare | NEOPROFEN | ibuprofen lysine | INJECTABLE;INTRAVENOUS | 021903-001 | Apr 13, 2006 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
